-
Something wrong with this record ?
Could the CCR5-Delta32 mutation be protective in SARS-CoV-2 infection
N. Starcevic Cizmarevic, M. Kapovic, D. Roncevic, S. Ristic
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
PubMed Central
from 2020
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- COVID-19 genetics immunology mortality virology MeSH
- Phenotype MeSH
- Gene Frequency MeSH
- Genetic Predisposition to Disease MeSH
- Host-Pathogen Interactions MeSH
- Humans MeSH
- Mutation * MeSH
- Protective Factors MeSH
- Prevalence MeSH
- Receptors, CCR5 genetics MeSH
- Risk Factors MeSH
- SARS-CoV-2 immunology pathogenicity MeSH
- Severity of Illness Index MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe MeSH
Increasing evidence points to host genetics as a factor in COVID-19 prevalence and outcome. CCR5 is a receptor for proinflammatory chemokines that are involved in host responses, especially to viruses. The CCR5-delta32 minor allele is an interesting variant, given the role of CCR5 in some viral infections, particularly HIV-1. Recent studies of the impact of CCR5-delta32 on COVID-19 risk and severity have yielded contradictory results. This ecologic study shows that the CCR5-delta32 allelic frequency in a European population was significantly negatively correlated with the number of COVID-19 cases (p=0.035) and deaths (p=0.006) during the second pandemic wave. These results suggest that CCR5-delta32 may be protective against SARS-CoV-2 infection, as it is against HIV infection, and could be predictive of COVID-19 risk and severity. Further studies based on samples from populations of different genetic backgrounds are needed to validate these statistically obtained findings.
Department of Medical Biology and Genetics Faculty of Medicine University of Rijeka Rijeka Croatia
Dobrica Rončević Primorje Gorski Kotar County Teaching Institute of Public Health Rijeka Croatia
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22000861
- 003
- CZ-PrNML
- 005
- 20220217135130.0
- 007
- ta
- 008
- 220106s2021 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934725 $2 doi
- 035 __
- $a (PubMed)34913355
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Starcevic Cizmarevic, N. $u Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
- 245 10
- $a Could the CCR5-Delta32 mutation be protective in SARS-CoV-2 infection / $c N. Starcevic Cizmarevic, M. Kapovic, D. Roncevic, S. Ristic
- 504 __
- $a Literatura
- 520 9_
- $a Increasing evidence points to host genetics as a factor in COVID-19 prevalence and outcome. CCR5 is a receptor for proinflammatory chemokines that are involved in host responses, especially to viruses. The CCR5-delta32 minor allele is an interesting variant, given the role of CCR5 in some viral infections, particularly HIV-1. Recent studies of the impact of CCR5-delta32 on COVID-19 risk and severity have yielded contradictory results. This ecologic study shows that the CCR5-delta32 allelic frequency in a European population was significantly negatively correlated with the number of COVID-19 cases (p=0.035) and deaths (p=0.006) during the second pandemic wave. These results suggest that CCR5-delta32 may be protective against SARS-CoV-2 infection, as it is against HIV infection, and could be predictive of COVID-19 risk and severity. Further studies based on samples from populations of different genetic backgrounds are needed to validate these statistically obtained findings.
- 650 _2
- $a COVID-19 $x genetika $x imunologie $x mortalita $x virologie $7 D000086382
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a interakce hostitele a patogenu $7 D054884
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a ochranné faktory $7 D065840
- 650 _2
- $a receptory CCR5 $x genetika $7 D019713
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a SARS-CoV-2 $x imunologie $x patogenita $7 D000086402
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kapovic, M. $u Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
- 700 1_
- $a Roncevic, D. $u Dobrica Rončević, Primorje-Gorski Kotar County Teaching Institute of Public Health, Rijeka, Croatia
- 700 1_
- $a Ristic, S. $u Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, Suppl. 2 (2021), s. S249-S252
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34913355 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20220106 $b ABA008
- 991 __
- $a 20220217135124 $b ABA008
- 999 __
- $a ok $b bmc $g 1761108 $s 1152007
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 70 $c S2 $d S249-S252 $e 20211216 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20220106